Release Date: 28/04/15 16:28 Summary: Despatch of Extraordinary General Meeting Materials Price Sensitive: No Download Document 1.23MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%